Palo Verde Cancer Specialists

What Palo Verde Cancer Specialists does

Palo Verde Cancer Specialists is a physician-owned and operated oncology practice headquartered in Glendale, Arizona, delivering comprehensive cancer care across six owned treatment centers in the Phoenix metropolitan area (Scottsdale, Glendale, Estrella/Phoenix, East Valley/Gilbert, West Valley) with service-area coverage extending to Payson. The practice operates as an integrated multi-modality platform spanning medical oncology (chemotherapy, immunotherapy, infusion), hematology, radiation oncology, PET-based diagnostic imaging, and a structured clinical trials program covering malignancies including pancreatic cancer, non-Hodgkin lymphoma, triple-negative and HER2-positive breast cancer, non-small cell lung cancer, and myelodysplastic syndrome. Care is delivered by a roster of 17+ medical and radiation oncologists with fellowship training at institutions such as the National Cancer Institute, City of Hope, MD Anderson, and the University of Texas Health Science Center, alongside nurse practitioners and physician assistants; the practice was the first ASCO-affiliated QOPI-certified oncology practice in Arizona and has participated in the program since April 2006.

The platform's technical backbone is capital-intensive radiation oncology: TomoTherapy (TomoHelical and TomoDirect modes with CTrue image guidance), Varian TrueBeam with Gated RapidArc for respiratory motion management, HDR brachytherapy, Xoft electronic brachytherapy for skin cancer, and AlignRT surface-guided patient positioning, supplemented by Siemens Biograph PET imaging with same-day reads. Underlying workflows include multidisciplinary tumor planning, infusion center operations, and increasingly digital patient engagement (online appointment scheduling, condition- and education-rich website, social presence on Facebook, X, Instagram, LinkedIn, and a third-party online bill-payment portal).

Revenue is generated primarily through professional-services billing to Medicare, Medicaid, and commercial insurance carriers, plus patient co-payments, with infusion and radiation oncology technical components layered on top; pricing is not publicly disclosed, payment plans are available, and major credit cards are accepted. Go-to-market is sales-led and referral-driven: new patients are acquired through primary care and specialist referrals, hospital partnerships (Banner Estrella, Banner Thunderbird, Paradise Valley, Scottsdale Healthcare), insurance networks, and direct inquiries, with first appointments typically scheduled within 2–7 days. The practice is privately held by its physician partners (President Dr. Amol N.S. Rakkar; Managing Partner Dr. Maqbool A. Halepota, MD), with no disclosed external venture, private equity, or institutional ownership.

Name

Palo Verde Cancer Specialists

Legal name

Palo Verde Cancer Specialists

Website

https://pvhomed.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Palo Verde Cancer Specialists is a physician-owned, multi-modality oncology practice operating six clinics across the Phoenix metro, delivering medical oncology, hematology, radiation therapy, immunotherapy, PET imaging, and clinical trials to cancer patients in Arizona.

Ownership category

akta.pro rank

Product category

Oncology Care Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Radiation Oncology (HLAKAFAC)

Keywords

• Hematology oncology services
• Radiation oncology treatment
• Cancer treatment center
• Infusion therapy services
• Diagnostic imaging services

Headquarters

HQ city

Glendale

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Medical Oncology Services: Professional medical services including chemotherapy administration, immunotherapy, and hematology treatments provided by board-certified oncologists and hematologists. Revenue generated through insurance billing, Medicare/Medicaid reimbursement, and patient co-payments.
2. Radiation Oncology Services: Advanced radiation therapy treatments including TomoTherapy, TrueBeam, and brachytherapy. Services billed based on treatment protocols and insurance coverage.
3. Diagnostic Imaging Services: PET scan imaging and laboratory services. Revenue generated through insurance claims and patient payments.
4. Infusion Center Services: Full-service infusion centers providing chemotherapy and other injectable treatments in a clinical setting.
5. Clinical Trial Participation: Participation in clinical trials for various cancer types including pancreatic cancer, lymphoma, breast cancer, and lung cancer, potentially generating revenue through research grants and pharmaceutical partnerships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Palo Verde Cancer Specialists delivers comprehensive cancer diagnosis and treatment across six Phoenix metro locations, combining medical oncology/chemotherapy, hematology, immunotherapy, infusion therapy, and advanced radiation oncology (TomoTherapy, TrueBeam, HDR brachytherapy, Xoft eBx) with on-site PET imaging (Siemens Biograph) and access to oncology clinical trials. The physician-owned practice integrates board-certified specialists, multidisciplinary treatment planning, and same-day diagnostics to provide individualized cancer care for adult oncology and hematology patients.

Product overview

Palo Verde Cancer Specialists is a comprehensive cancer treatment center operating six facilities in the Phoenix, Arizona metropolitan area (Scottsdale, Glendale, Estrella, East Valley, West Valley, and Payson). The practice offers an integrated portfolio of cancer care services centered around medical oncology/chemotherapy, hematology, immunotherapy, and advanced radiation oncology. Key radiation therapy technology includes TomoTherapy (TomoHelical and TomoDirect), TrueBeam (Varian), HDR brachytherapy, Xoft electronic brachytherapy, and AlignRT. The center also provides PET scan imaging (Siemens Biograph), access to clinical trials, and treats over 17 cancer types including breast, lung, colorectal, prostate, brain, pancreatic, head and neck, gynecologic, skin, liver, kidney, bladder, and lymphomas. The practice is physician-owned and operated, staffed by board-certified hematologists, oncologists, and radiation oncologists.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology / Chemotherapy Chemotherapy treatment using potent drugs to destroy cancer cells or inhibit their growth, administered intravenously or orally as a primary or adjunct cancer treatment, delivered by board-certified medical oncologists across Palo Verde's Phoenix metro clinic locations.
• Hematology Diagnosis and treatment of blood diseases and blood cancers including anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma, providing blood products, chemotherapy, stem cell therapy, and supportive care for patients with hematologic disorders.
• Immunotherapy Cancer treatment designed to help the immune system fight cancer by marking cancer cells for destruction, including checkpoint inhibitors, adoptive cell transfer, monoclonal antibodies, and treatment vaccines administered through the practice's infusion centers.
• PET Scan Imaging Positron emission tomography imaging using Siemens Biograph technology to identify cancer location and stage for treatment planning, with same-day results and immediate appointment availability across major insurance plans.
• Clinical Trials Access to oncology clinical trials for multiple cancer types including myelodysplastic syndrome, pancreatic cancer, non-Hodgkin lymphoma, triple-negative breast cancer, HER2-positive breast cancer, and non-small cell lung cancer, with Dr. Rakkar serving as Principal Investigator.
• TomoTherapy Radiation Therapy Advanced image-guided radiation therapy combining daily CT imaging with precise radiation beam delivery in 360-degree fan-beam rotation, offering TomoHelical and TomoDirect delivery modes with CTrue imaging technology for patient positioning and movement monitoring.
• TrueBeam Radiation Therapy Varian Medical Systems radiotherapy platform delivering high-dose radiation with sub-millimeter precision, featuring Gated RapidArc motion tracking and treatment times under two minutes for lung, breast, prostate, head and neck, and other cancers.
• High-Dose-Rate (HDR) Brachytherapy Internal radiation therapy delivering high-dose radiation via implants placed inside the body, used for skin cancer and other cancer types with treatment courses reduced to 6-10 sessions versus 20-30 external beam treatments.
• Xoft Electronic Brachytherapy (eBx) Electronic brachytherapy system for treating skin cancer lesions close to the skin surface, offering a non-invasive alternative to surgery with no scarring.

Quantifiable outcome

• QOPI certification - first practice certified in Arizona
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Arizona Oncology Associates: Large community oncology practice operating multiple sites across the Phoenix metro and Arizona with medical oncology, hematology, and radiation oncology services — the most direct head-to-head competitor for PVCS in the same geography.
• Ironwood Cancer & Research Centers: Phoenix-metro community oncology and radiation practice offering medical oncology, hematology, radiation therapy, imaging, and clinical trials across multiple East Valley and West Valley locations — overlapping service mix and patient geography with PVCS.
• Tennessee Oncology: One of the largest independent community oncology practices in the U.S. with multi-modality services including radiation, infusion, imaging, and clinical trials — analogous business model and scale profile to PVCS, frequently cited as a benchmark independent oncology platform.
• Florida Cancer Specialists & Research Institute: Large independent community oncology practice combining medical oncology, hematology, radiation, imaging, and clinical research across dozens of Florida locations — same multi-modality independent model and comparable scale to PVCS.

Emerging players

• OneOncology: National platform partnership for independent community oncology practices providing capital, technology, and operational support — a potential partner, acquirer, or roll-up competitor to PVCS as it scales.

Broad incumbents

• US Oncology Network (McKesson): National network of community oncology practices (now part of McKesson) offering practice management, payer contracting, and clinical research — broadly comparable operating model to PVCS at national scale.
• City of Hope (formerly Cancer Treatment Centers of America): National cancer care system with hospital-based and outpatient locations providing comprehensive oncology services including advanced radiation and clinical trials — competes with PVCS for complex oncology cases in the broader Western U.S. catchment.
• Banner MD Anderson Cancer Center: Hospital-affiliated comprehensive cancer program in Phoenix metro and Gilbert offering medical oncology, radiation oncology, and clinical trials through partnership with MD Anderson — competing system in the same geography with deeper capital and academic affiliation.
• HonorHealth Cancer Care: Multi-hospital health system in the Phoenix metro with integrated oncology services across multiple sites — competes with PVCS for community oncology referrals and represents the broader hospital-system competitive threat.

Regional players

• Mayo Clinic Arizona: Academic medical center in Scottsdale offering comprehensive cancer care including advanced radiation, complex oncology, and clinical trials — competes for high-acuality oncology cases in the same Phoenix geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pvhomed
• Facebookfacebook.com/pvhomed
• LinkedInlinkedin.com/company/palo-verde-cancer-specialists/posts/?feedView=all
• Instagraminstagram.com/paloverdecancerspecialists

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Palo Verde Cancer Specialists